Prescription Drug Supply Chain Pricing Transparency Act mandates a study on compensation and payment structures in the prescription drug supply chain.
The Prescription Drug Supply Chain Pricing Transparency Act requires the Comptroller General to study compensation and payment structures in the prescription drug supply chain. The study will cover types, magnitude, and prevalence of compensation structures, variations between affiliated and unaffiliated entities, and potential conflicts of interest. It will also examine patterns and trends in price-based compensation structures over time and between different market segments.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.